Recent Posts

Nicholas Vogelzang Presents at Perrin Conferences

March 21, 2019 | By Nicholas Vogelzang

I was recently given the opportunity to speak at the Perrin Cutting-Edge Issues in Asbestos Litigation Conference in Beverly Hills, California. This conference is unique in that, unlike most conferences for lawyers involved in a particular area of litigation, it brings together lawyers representing both sides, in addition to insurance carriers that ultimately pay the […]

Continue reading

Nicholas Vogelzang Presents at National Asbestos Litigation Conference

October 2, 2018 | By swarren

On Monday afternoon, Lead Counsel Nicholas Vogelzang of Vogelzang Law presented as part of the National Asbestos Litigation Conference hosted by Perrin Conferences, an event which brings attorneys together from across the country to discuss new and emerging topics in asbestos litigation. Vogelzang spoke as part of a panel discussing recent verdicts and analyzing their […]

Continue reading

Kellogg Cancer Center in Evanston

March 22, 2017

My name is Mirela Stefanescu. This was my fifth social to attend and I now I feel like an old pro. The Kellogg Cancer Center in Evanston was a beautiful location with lots of greenery in the waiting room. We set up in a room off to the left. The unique part of this location is that it provided us with two screens on which we played clips representative of Imerman Angels as well as interviews with both the founder Johnny and with other mentor angels. 

Mesothelioma Settlement for Wife of Union Electrician

November 15, 2016

Attorney Nicholas Vogelzang settled yet another mesothelioma case for an undisclosed high dollar amount on November 8, 2016 at the Daley Center in Cook County.  His client was the wife of a union electrician out of IBEW Local 134 in Chicago.  She had laundered his clothing throughout his working career.  Most notably she shook out […]

Continue reading


July 29, 2016

A clinical study of malignant pleural mesothelioma patients treated with investigational cancer vaccine CRS-207 at University of Chicago Medical Center, UCSF’s cancer center, the Moffitt Cancer Center in Tampa, the Abramson Cancer Center in Philadelphia and the National Cancer Institutein Bethesda, Maryland has shown promising results in shrinking tumors. CRS-207 caused tumor shrinkage in 85% of […]

Continue reading